Nancy Fryzek

515 total citations
7 papers, 316 citations indexed

About

Nancy Fryzek is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Nancy Fryzek has authored 7 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 5 papers in Epidemiology and 2 papers in Immunology. Recurrent topics in Nancy Fryzek's work include Liver Disease Diagnosis and Treatment (4 papers), Hepatitis C virus research (3 papers) and Hepatitis B Virus Studies (2 papers). Nancy Fryzek is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Hepatitis C virus research (3 papers) and Hepatitis B Virus Studies (2 papers). Nancy Fryzek collaborates with scholars based in United States. Nancy Fryzek's co-authors include T. Jake Liang, Marc G. Ghany, Xenia Chepa-Lotrea, Barbara Rehermann, Elisavet Serti, Yun Ju Kim, Yaron Rotman, Ohad Etzion, Varun Takyar and Theo Heller and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Nancy Fryzek

6 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy Fryzek United States	5	253	238	63	20	15	7	316
Ming‐Yen Hsieh Taiwan	6	245 1.0×	213 0.9×	18 0.3×	25 1.3×	12 0.8×	13	284
T. Gerlach Germany	6	241 1.0×	186 0.8×	75 1.2×	35 1.8×	9 0.6×	12	304
Namiki Izumi Japan	9	284 1.1×	241 1.0×	24 0.4×	36 1.8×	30 2.0×	17	328
Waleed Al–Hamoudi Saudi Arabia	14	322 1.3×	362 1.5×	35 0.6×	15 0.8×	18 1.2×	29	424
Carl Janssen Belgium	6	82 0.3×	140 0.6×	62 1.0×	15 0.8×	17 1.1×	7	255
Chitomi Hasebe Japan	10	223 0.9×	212 0.9×	22 0.3×	12 0.6×	11 0.7×	29	304
I. Ketikoglou Greece	13	481 1.9×	454 1.9×	51 0.8×	44 2.2×	37 2.5×	32	609
Tsugiko Oze Japan	12	297 1.2×	262 1.1×	68 1.1×	19 0.9×	16 1.1×	24	367
Alicia Sáez Spain	8	149 0.6×	176 0.7×	72 1.1×	36 1.8×	38 2.5×	10	329
Céline Dorival France	8	145 0.6×	146 0.6×	27 0.4×	16 0.8×	14 0.9×	28	228

Countries citing papers authored by Nancy Fryzek

Since Specialization

Citations

This map shows the geographic impact of Nancy Fryzek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Fryzek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Fryzek more than expected).

Fields of papers citing papers by Nancy Fryzek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Fryzek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Fryzek. The network helps show where Nancy Fryzek may publish in the future.

Co-authorship network of co-authors of Nancy Fryzek

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Fryzek. A scholar is included among the top collaborators of Nancy Fryzek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Fryzek. Nancy Fryzek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Gara, Naveen, Michele Tana, Sungyoung Auh, et al.. (2021). Prospective Study of Withdrawal of Antiviral Therapy in Patients with Chronic Hepatitis B after Prolonged Virological Response. Hepatology Communications. 5(11). 1888–1900. 4 indexed citations

2.

Yang, Shanna, et al.. (2019). Dietary fatty acid oxidation is decreased in non‐alcoholic fatty liver disease: A palmitate breath test study. Liver International. 40(3). 590–597. 22 indexed citations

3.

Surana, Pallavi, Susan L. Uprichard, Ma Ai Thanda Han, et al.. (2018). Pharmacokinetics and pharmacodynamics modeling of ritonavir boosted lonafarnib therapy in HDV patients: A phase 2 LOWR HDV-3 study. Journal of Hepatology. 68. S508–S508.

4.

Yakov, Gil Ben, Hawwa Alao, John P. Haydek, et al.. (2018). Development of Hepatic Steatosis After Chemotherapy for Non‐Hodgkin Lymphoma. Hepatology Communications. 3(2). 220–226. 9 indexed citations

5.

Koh, Christopher, Pallavi Surana, Nancy Fryzek, et al.. (2017). A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis – end of study results from the LOWR HDV-3 study. Journal of Hepatology. 66(1). S101–S102. 37 indexed citations

6.

Takyar, Varun, Ohad Etzion, Theo Heller, et al.. (2017). Complications of percutaneous liver biopsy with Klatskin needles: a 36‐year single‐centre experience. Alimentary Pharmacology & Therapeutics. 45(5). 744–753. 52 indexed citations

7.

Serti, Elisavet, Xenia Chepa-Lotrea, Yun Ju Kim, et al.. (2015). Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function. Gastroenterology. 149(1). 190–200.e2. 192 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact